Intriguingly, a novel computational approach termed disruption networks revealed in a recent study that the RAC1-PAK1 signaling cascade is associated with TNF-α inhibitor response in RA and IBD patients. The gene discussed is RAC1; the disease is inflammatory bowel disease.